345 related articles for article (PubMed ID: 14744150)
1. Characterization of the adenosinetriphosphatase and transport activities of purified cystic fibrosis transmembrane conductance regulator.
Ketchum CJ; Rajendrakumar GV; Maloney PC
Biochemistry; 2004 Feb; 43(4):1045-53. PubMed ID: 14744150
[TBL] [Abstract][Full Text] [Related]
2. Protein kinase A regulates ATP hydrolysis and dimerization by a CFTR (cystic fibrosis transmembrane conductance regulator) domain.
Howell LD; Borchardt R; Kole J; Kaz AM; Randak C; Cohn JA
Biochem J; 2004 Feb; 378(Pt 1):151-9. PubMed ID: 14602047
[TBL] [Abstract][Full Text] [Related]
3. Prolonged nonhydrolytic interaction of nucleotide with CFTR's NH2-terminal nucleotide binding domain and its role in channel gating.
Basso C; Vergani P; Nairn AC; Gadsby DC
J Gen Physiol; 2003 Sep; 122(3):333-48. PubMed ID: 12939393
[TBL] [Abstract][Full Text] [Related]
4. Nucleotide occlusion in the human cystic fibrosis transmembrane conductance regulator. Different patterns in the two nucleotide binding domains.
Szabó K; Szakács G; Hegeds T; Sarkadi B
J Biol Chem; 1999 Apr; 274(18):12209-12. PubMed ID: 10212185
[TBL] [Abstract][Full Text] [Related]
5. ATPase activity of the cystic fibrosis transmembrane conductance regulator.
Li C; Ramjeesingh M; Wang W; Garami E; Hewryk M; Lee D; Rommens JM; Galley K; Bear CE
J Biol Chem; 1996 Nov; 271(45):28463-8. PubMed ID: 8910473
[TBL] [Abstract][Full Text] [Related]
6. A novel procedure for the efficient purification of the cystic fibrosis transmembrane conductance regulator (CFTR).
Ramjeesingh M; Li C; Garami E; Huan LJ; Hewryk M; Wang Y; Galley K; Bear CE
Biochem J; 1997 Oct; 327 ( Pt 1)(Pt 1):17-21. PubMed ID: 9355728
[TBL] [Abstract][Full Text] [Related]
7. Lysophosphatidylglycerol: a novel effective detergent for solubilizing and purifying the cystic fibrosis transmembrane conductance regulator.
Huang P; Liu Q; Scarborough GA
Anal Biochem; 1998 May; 259(1):89-97. PubMed ID: 9606148
[TBL] [Abstract][Full Text] [Related]
8. The intact CFTR protein mediates ATPase rather than adenylate kinase activity.
Ramjeesingh M; Ugwu F; Stratford FL; Huan LJ; Li C; Bear CE
Biochem J; 2008 Jun; 412(2):315-21. PubMed ID: 18241200
[TBL] [Abstract][Full Text] [Related]
9. Direct interaction of a small-molecule modulator with G551D-CFTR, a cystic fibrosis-causing mutation associated with severe disease.
Pasyk S; Li C; Ramjeesingh M; Bear CE
Biochem J; 2009 Feb; 418(1):185-90. PubMed ID: 18945216
[TBL] [Abstract][Full Text] [Related]
10. How Phosphorylation and ATPase Activity Regulate Anion Flux though the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR).
Zwick M; Esposito C; Hellstern M; Seelig A
J Biol Chem; 2016 Jul; 291(28):14483-98. PubMed ID: 27226582
[TBL] [Abstract][Full Text] [Related]
11. ATP hydrolysis by a CFTR domain: pharmacology and effects of G551D mutation.
Howell LD; Borchardt R; Cohn JA
Biochem Biophys Res Commun; 2000 May; 271(2):518-25. PubMed ID: 10799328
[TBL] [Abstract][Full Text] [Related]
12. Cystic fibrosis transmembrane conductance regulator (CFTR) nucleotide-binding domain 1 (NBD-1) and CFTR truncated within NBD-1 target to the epithelial plasma membrane and increase anion permeability.
Clancy JP; Hong JS; Bebök Z; King SA; Demolombe S; Bedwell DM; Sorscher EJ
Biochemistry; 1998 Oct; 37(43):15222-30. PubMed ID: 9790686
[TBL] [Abstract][Full Text] [Related]
13. ATPase assay of purified, reconstituted CFTR protein.
Kogan I; Ramjeesingh M; Bear CE
J Cyst Fibros; 2004 Aug; 3 Suppl 2():133-4. PubMed ID: 15463945
[TBL] [Abstract][Full Text] [Related]
14. Differential interactions of nucleotides at the two nucleotide binding domains of the cystic fibrosis transmembrane conductance regulator.
Aleksandrov L; Mengos A; Chang X; Aleksandrov A; Riordan JR
J Biol Chem; 2001 Apr; 276(16):12918-23. PubMed ID: 11279083
[TBL] [Abstract][Full Text] [Related]
15. Conserved allosteric hot spots in the transmembrane domains of cystic fibrosis transmembrane conductance regulator (CFTR) channels and multidrug resistance protein (MRP) pumps.
Wei S; Roessler BC; Chauvet S; Guo J; Hartman JL; Kirk KL
J Biol Chem; 2014 Jul; 289(29):19942-57. PubMed ID: 24876383
[TBL] [Abstract][Full Text] [Related]
16. Review. ATP hydrolysis-driven gating in cystic fibrosis transmembrane conductance regulator.
Muallem D; Vergani P
Philos Trans R Soc Lond B Biol Sci; 2009 Jan; 364(1514):247-55. PubMed ID: 18957373
[TBL] [Abstract][Full Text] [Related]
17. Functional roles of nonconserved structural segments in CFTR's NH2-terminal nucleotide binding domain.
Csanády L; Chan KW; Nairn AC; Gadsby DC
J Gen Physiol; 2005 Jan; 125(1):43-55. PubMed ID: 15596536
[TBL] [Abstract][Full Text] [Related]
18. The two nucleotide-binding domains of cystic fibrosis transmembrane conductance regulator (CFTR) have distinct functions in controlling channel activity.
Carson MR; Travis SM; Welsh MJ
J Biol Chem; 1995 Jan; 270(4):1711-7. PubMed ID: 7530246
[TBL] [Abstract][Full Text] [Related]
19. CFTR directly mediates nucleotide-regulated glutathione flux.
Kogan I; Ramjeesingh M; Li C; Kidd JF; Wang Y; Leslie EM; Cole SP; Bear CE
EMBO J; 2003 May; 22(9):1981-9. PubMed ID: 12727866
[TBL] [Abstract][Full Text] [Related]
20. Electrodiffusional ATP movement through the cystic fibrosis transmembrane conductance regulator.
Cantiello HF; Jackson GR; Grosman CF; Prat AG; Borkan SC; Wang Y; Reisin IL; O'Riordan CR; Ausiello DA
Am J Physiol; 1998 Mar; 274(3):C799-809. PubMed ID: 9530112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
